BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29793797)

  • 21. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.
    Abu-Ghanem Y; Ramon J; Berger R; Kaver I; Fridman E; Leibowitz-Amit R; Dotan ZA
    World J Surg Oncol; 2017 Nov; 15(1):193. PubMed ID: 29096642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perioperative management and oncological outcomes following radical cystectomy for bladder cancer: a matched retrospective cohort study.
    Weingarten TN; Taccolini AM; Ahle ST; Dietz KR; Dowd SS; Frank I; Boorjian SA; Thapa P; Hanson AC; Schroeder DR; Sprung J
    Can J Anaesth; 2016 May; 63(5):584-95. PubMed ID: 26850064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
    Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
    World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.
    Lam JS; Shvarts O; Leppert JT; Pantuck AJ; Figlin RA; Belldegrun AS
    J Urol; 2005 Aug; 174(2):466-72; discussion 472; quiz 801. PubMed ID: 16006866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are Allogeneic Blood Transfusions Associated With Decreased Survival After Surgery for Long-bone Metastatic Fractures?
    Janssen SJ; Braun Y; Ready JE; Raskin KA; Ferrone ML; Hornicek FJ; Schwab JH
    Clin Orthop Relat Res; 2015 Jul; 473(7):2343-51. PubMed ID: 25637400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
    Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
    BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma.
    Kim SP; Weight CJ; Leibovich BC; Thompson RH; Costello BA; Cheville JC; Lohse CM; Boorjian SA
    Urology; 2011 Nov; 78(5):1101-6. PubMed ID: 21903243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection.
    Gershman B; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2017 Aug; 72(2):300-306. PubMed ID: 28094055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association between metformin use and oncologic outcomes among surgically treated diabetic patients with localized renal cell carcinoma.
    Psutka SP; Boorjian SA; Lohse CM; Stewart SB; Tollefson MK; Cheville JC; Leibovich BC; Thompson RH
    Urol Oncol; 2015 Feb; 33(2):67.e15-23. PubMed ID: 25153774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laparoscopic resection of local recurrence after previous radical nephrectomy for clinically localized renal-cell carcinoma: perioperative outcomes and initial observations.
    Yohannan J; Feng T; Berkowitz J; Connolly SS; Pierorazio P; Allaf ME
    J Endourol; 2010 Oct; 24(10):1609-12. PubMed ID: 20629564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study.
    Lee H; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
    BJU Int; 2017 Feb; 119(2):261-267. PubMed ID: 27226065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of Postoperative Complications in Patients Who Undergo Radical Nephrectomy and IVC Thrombectomy: A Large Contemporary Tertiary Center Analysis.
    Lue K; Russell CM; Fisher J; Kurian T; Agarwal G; Luchey A; Poch M; Pow-Sang JM; Sexton WJ; Spiess PE
    Clin Genitourin Cancer; 2016 Feb; 14(1):89-95. PubMed ID: 26453395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC).
    Capitanio U; Suardi N; Matloob R; Roscigno M; Abdollah F; Di Trapani E; Moschini M; Gallina A; Salonia A; Briganti A; Montorsi F; Bertini R
    BJU Int; 2014 Aug; 114(2):210-5. PubMed ID: 24854206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis.
    Schmitges J; Trinh QD; Sun M; Hansen J; Bianchi M; Jeldres C; Perrotte P; Dahlem R; Shariat SF; Chun FK; Montorsi F; Menon M; Fisch M; Graefen M; Karakiewicz PI
    BJU Int; 2012 Sep; 110(6 Pt B):E183-90. PubMed ID: 22321256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of perioperative blood transfusion on prognosis after nephrectomy in patients with renal cell carcinoma: A meta-analysis and systematic review.
    Xu J; Bai J; Pan H; Zhou Z
    Medicine (Baltimore); 2024 Apr; 103(14):e37646. PubMed ID: 38579099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of beta-blockers and survival among hypertensive patients with renal cell carcinoma.
    Parker WP; Lohse CM; Zaid HB; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Urol Oncol; 2017 Jan; 35(1):36.e1-36.e6. PubMed ID: 27687543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality?
    Abel EJ; Linder BJ; Bauman TM; Bauer RM; Thompson RH; Thapa P; Devon ON; Tarrell RF; Frank I; Jarrard DF; Downs TM; Boorjian SA
    Eur Urol; 2014 Dec; 66(6):1139-47. PubMed ID: 25194909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy.
    Moreira DM; Gershman B; Lohse CM; Boorjian SA; Cheville JC; Leibovich BC; Thompson RH
    World J Urol; 2016 Oct; 34(10):1465-72. PubMed ID: 26914818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival analysis of surgically treated renal cell carcinoma: a single Chinese medical center experience from 2002 to 2012.
    Zhang Y; Yu H; Li H
    Int Urol Nephrol; 2015 Aug; 47(8):1327-33. PubMed ID: 26163269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of blood transfusion on survival after nephrectomy for localized or locally advanced renal cancer.
    Détrée P; Balssa L; Richard V; Francois C; Barkatz J; Bernardini S; Chabannes E; Guichard G; Thiery-Vuillemin A; Kleinclauss F; Frontczak A
    Prog Urol; 2022 Jul; 32(8-9):577-584. PubMed ID: 35523663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.